NDC 73499-001

Wynzora

Calcipotriene And Betamethasone Dipropionate

Wynzora is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Mc2 Therapeutics Ltd. The primary component is Calcipotriene; Betamethasone Dipropionate.

Product ID73499-001_252abab8-2793-46c6-9af0-7a88ecf41a36
NDC73499-001
Product TypeHuman Prescription Drug
Proprietary NameWynzora
Generic NameCalcipotriene And Betamethasone Dipropionate
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2021-06-30
Marketing CategoryNDA /
Application NumberNDA213422
Labeler NameMC2 Therapeutics Ltd
Substance NameCALCIPOTRIENE; BETAMETHASONE DIPROPIONATE
Active Ingredient Strength50 ug/g; mg/g
Pharm ClassesVitamin D [CS],Vitamin D Analog [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 73499-001-01

1 TUBE in 1 CARTON (73499-001-01) > 60 g in 1 TUBE
Marketing Start Date2021-06-30
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Wynzora" or generic name "Calcipotriene And Betamethasone Dipropionate"

NDCBrand NameGeneric Name
73499-001WynzoraCalcipotriene and Betamethasone dipropionate
0781-7165CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATEcalcipotriene and betamethasone dipropionate
45802-889calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionate
45802-989Calcipotriene and Betamethasone Dipropionatecalcipotriene and betamethasone dipropionate
51672-1402Calcipotriene and Betamethasone DipropionateCalcipotriene and Betamethasone Dipropionate
63629-8618calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionate
63629-8619calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionate
63646-040calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionate
66993-937Calcipotriene and Betamethasone DipropionateCalcipotriene and Betamethasone Dipropionate
66993-938Calcipotriene and Betamethasone DipropionateCalcipotriene and Betamethasone Dipropionate
50222-302ENSTILARcalcipotriene and betamethasone dipropionate
50222-227Taclonexcalcipotriene and betamethasone dipropionate
50222-501TACLONEXcalcipotriene and betamethasone dipropionate

Trademark Results [Wynzora]

Mark Image

Registration | Serial
Company
Trademark
Application Date
WYNZORA
WYNZORA
79258125 not registered Live/Pending
Horten Advokatpartnerselskab
2019-02-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.